Brello Health vs Hims
Brello Health costs $41.28 less a month, and both sell semaglutide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Brello Health
Best for: seeing what it charges before you answer any medical questions
Visit Brello Health →
Hims
Best for: knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC
Visit Hims →If you are choosing between Brello Health and Hims, the first difference is cost: Brello Health is $41.28 a month cheaper at the entry price. Both prescribe semaglutide, so moving from one to the other would not change your drug. Brello Health leads our six-part score, 7.4 to 6.8. One of the two has an FDA warning letter on record, covered below.
Brello Health vs Hims price
Brello Health is the cheaper way in: $157.72 a month against $199 a month at Hims. That is $41.28 less each month (21% lower), or about $495.36 over a year of treatment.
Drug by drug: Semaglutide is cheaper at Brello Health ($157.72 a month vs $199 a month).
Medications and formats
Both sell semaglutide; only Hims lists tirzepatide.
On format, Brello Health prices compounded injections, while Hims prices compounded injections and brand-name pens.
If you want the FDA-approved brand rather than a compounded version, Hims is the only one of the two with a brand-name price.
Where each one treats patients
Brello Health lists 35 states, and Hims lists 50 states.
They overlap in 34 states. Brello Health alone covers District of Columbia. Hims alone covers 16 states, including Alabama, Arkansas, California and Connecticut.
Pricing
Brello Health
Hims
Brand Zepbound from $299/mo medication-only; requires Hims Weight Loss Membership ($149/mo)
What each price covers
Both prices cover the medication itself.
Brello Health's price also covers the clinician visit, which Hims does not claim.
Brello Health is silent on shipping, lab work and coaching.
Hims is silent on shipping and lab work.
Brello Health
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
Hims
Covered by the monthly price
Medication
In the price
Clinician visits
Charged on top
Shipping
Not stated
Lab work
Not stated
Coaching
Charged on top
Where each one scores higher
Overall, Brello Health scores 7.4 and Hims 6.8 out of 10.
Brello Health is stronger on value (6.1 vs 3.0), trust & safety (8.5 vs 7.0) and support (5.5 vs 3.0).
Hims is stronger on effectiveness (10.0 vs 8.5) and accessibility (10.0 vs 7.6).
User experience is within half a point.
Brello Health
7.4/10
Hims
6.8/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent Hims a warning letter dated September 9, 2025 (letter 716567), and it is still open.
Brello Health has no FDA warning letter on record with us.
Features & Coverage
| Feature | Brello Health | Hims |
|---|---|---|
| Starting Price | ✓$157.72/mo | $199/mo |
| Features | 2 features | 2 features |
| States Available | 35 | ✓50 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | ✓None | 1 letter |
About Brello Health
Brello Health is a telehealth wellness platform selling GLP-1 weight management.
Read our full Brello Health review →About Hims
Hims is a major men's telehealth brand. Its weight loss offering is compounded semaglutide on a 6-month plan.
Read our full Hims review →Pros & Cons
Brello Health
What we like
- Semaglutide costs $157.72 a month, 14% below the $184 median for compounded semaglutide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication and clinician visits
- We found no FDA warning letters issued to Brello Health
Watch-outs
- Serves only 35 states, so check that yours is one of them
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Hims
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication
- Serves all 50 states
- Names 4 pharmacies that fill its prescriptions, which most sellers do not
Watch-outs
- Not included in the monthly price: clinician visits, coaching
- The FDA has issued Hims a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Brello Health wins this one, 7.4 to 6.8, above all for seeing what it charges before you answer any medical questions. It also costs $41.28 less each month than Hims. Hims fits better if knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC is your priority.
Choose Brello Health if…
You want seeing what it charges before you answer any medical questions and an opening price near $157.72 a month.
Choose Hims if…
You want knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC and an opening price near $199 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
He & She MD
Starting below a standard dose, with microdose tiers
From $99/mo
Get started →Wellorithm
Compounded semaglutide at $247/month
From $247/mo
Get started →Willow
Seeing what it charges before you answer any medical questions
From $299/mo
Get started →Brello Health vs Hims: FAQ
Close alternatives to Brello Health and Hims
- Brello Health vs AM Rx
- Brello Health vs FitRx
- Brello Health vs SynergenX Health
- Brello Health vs Dr. Gillis' Wellness Center
- Hims vs Hers
- Hims vs Noom
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.